These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30080688)

  • 1. Unusual Presentation of Hurthle Cell Carcinoma With TENIS Syndrome as Left Atrial Thrombus on 18F-FDG PET/CT.
    Sood A; Parihar AS; Sood A; Kumar R; Prakash G; Singhal M; Gulati A; Mittal BR; Bahl A; Singh S
    Clin Nucl Med; 2018 Oct; 43(10):e352-e354. PubMed ID: 30080688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT.
    Verma P; Malhotra G; Meshram V; Chandak A; Sonavane S; Lila AR; Bandgar TR; Asopa RV
    Clin Nucl Med; 2021 Aug; 46(8):e406-e409. PubMed ID: 33883490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-FAPI PET/CT in Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy.
    Fu H; Fu J; Huang J; Su X; Chen H
    Clin Nucl Med; 2021 May; 46(5):427-430. PubMed ID: 33661204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
    Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
    J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of 68Ga-DOTA-RGD (αvβ3) PET/CT Imaging in Thyroglobulin Elevation With Negative Iodine Scintigraphy.
    Vatsa R; Shykla J; Mittal BR; Bhusari P; Sood A; Basher RK; Bhattacharya A
    Clin Nucl Med; 2017 Jun; 42(6):471-472. PubMed ID: 28346249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hürthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT.
    Tang K; Wang Z; Lin J; Zheng X
    Clin Nucl Med; 2020 Mar; 45(3):223-224. PubMed ID: 31876816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-Avid Hürthle Cell Thyroid Adenoma.
    Yu R; Auerbach MS
    Clin Nucl Med; 2019 Sep; 44(9):752-753. PubMed ID: 31135518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin.
    Binse I; Poeppel TD; Ruhlmann M; Ezziddin S; Görges R; Sabet A; Beiderwellen K; Bockisch A; Rosenbaum-Krumme SJ
    J Nucl Med; 2016 Oct; 57(10):1512-1517. PubMed ID: 27033897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grouping of Metastatic Thyroid Carcinoma by Molecular Imaging Features to Allow for Individualized Treatment, with Emphasis on the TENIS Syndrome.
    Basu S; Parghane RV
    J Nucl Med Technol; 2016 Sep; 44(3):184-9. PubMed ID: 27493262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
    Ranade R; Kand P; Basu S
    Nucl Med Commun; 2015 Oct; 36(10):1014-20. PubMed ID: 26049373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated Review.
    Chandekar KR; Satapathy S; Bal C
    PET Clin; 2024 Apr; 19(2):131-145. PubMed ID: 38212213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron Emission Tomography/Computed Tomography in Thyroid Cancer.
    Bal C; Chakraborty D; Khan D
    PET Clin; 2022 Apr; 17(2):265-283. PubMed ID: 35256297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
    Ong SC; Ng DC; Sundram FX
    Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
    Mirallié E; Guillan T; Bridji B; Resche I; Rousseau C; Ansquer C; Bodet-Milin C; Curtet C; Carnaille B; Murat A; Charbonnel B; Kraeber-Bodéré F
    Surgery; 2007 Dec; 142(6):952-8; discussion 952-8. PubMed ID: 18063081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care.
    Basu S; Parghane RV
    PET Clin; 2017 Jan; 12(1):27-37. PubMed ID: 27863564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between positive thyroglobulin doubling time and 18F-FDG PET/CT-positive, 131I-negative lesions.
    Kelders A; Kennes LN; Krohn T; Behrendt FF; Mottaghy FM; Verburg FA
    Nucl Med Commun; 2014 Feb; 35(2):176-81. PubMed ID: 24201550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlesional 'flip-flop' between
    Basu S; Kalshetty A; Fargose P
    Natl Med J India; 2017; 30(1):48. PubMed ID: 28731009
    [No Abstract]   [Full Text] [Related]  

  • 18. 18F-FDG PET of patients with Hürthle cell carcinoma.
    Lowe VJ; Mullan BP; Hay ID; McIver B; Kasperbauer JL
    J Nucl Med; 2003 Sep; 44(9):1402-6. PubMed ID: 12960183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
    Bertagna F; Albano D; Bosio G; Piccardo A; Dib B; Giubbini R
    Curr Radiopharm; 2016; 9(3):228-234. PubMed ID: 27210819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.